Glenmark anti-myeloma drug gets clinical trial nod from USFDA

This is Glenmark's second investigational new drug from its immuno-oncology portfolio to enter clinical trials.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news